- Active not recruitingPHASE3
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
This study is testing a new medicine, ianalumab, for people with active Sjögren's syndrome. Researchers want to see if it's safe and helps improve symptoms. Participants will receive either the new medicine or a dummy medicine called a placebo.
For: Sjogren SyndromeUnited States · Argentina · Australia - Active not recruitingPHASE3
Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
This study is testing a new medicine called ianalumab (VAY736) for active Sjogren's Syndrome. It will compare ianalumab to a dummy medicine (placebo) to see if it's safe and helps improve symptoms. This is a large, important study.
For: Sjogren SyndromeUnited States · Austria · Belgium